Literature DB >> 8632712

Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch.

S Takai1, N Shiota, D Yamamoto, H Okunishi, M Miyazaki.   

Abstract

Hamster cheek pouch vascular tissues contain an angiotensin II-forming enzyme which is inhibited by chymostatin but not by any angiotensin-converting enzyme inhibitors. The enzyme was purified to apparent homogeneity by gel filtration and heparin-Sepharose affinity chromatography. The molecular mass estimated by sodium dodecyl sulphate polyacrylamide gel electrophoresis was 28 kDa and the optimum pH was between 7.5 and 9.0. The angiotensin II-forming activity was inhibited by chymostatin, soybean trypsin inhibitor and phenylmethylsulfonyl fluoride, but not by aprotinin. The N-terminal sequence showed high homology with chymases from various species. Thus, the angiotensin II-generating enzyme obtained from hamster cheek pouch vessels is a chymase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632712     DOI: 10.1016/0024-3205(95)02328-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

1.  Possible roles of mast cell-derived chymase for skin rejuvenation.

Authors:  Nobuyuki Amano; Shinji Takai; Denan Jin; Koichi Ueda; Mizuo Miyazaki
Journal:  Lasers Med Sci       Date:  2008-04-12       Impact factor: 3.161

2.  Cloning of the gene and cDNA for hamster chymase 2, and expression of chymase 1, chymase 2 and angiotensin-converting enzyme in the terminal stage of cardiomyopathic hearts.

Authors:  N Shiota; A Fukamizu; H Okunishi; S Takai; K Murakami; M Miyazaki
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

Review 3.  Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.

Authors:  Louis J Dell'Italia; James F Collawn; Carlos M Ferrario
Journal:  Circ Res       Date:  2018-01-19       Impact factor: 17.367

Review 4.  Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis.

Authors:  Shinji Takai; Denan Jin
Journal:  Front Pharmacol       Date:  2018-02-21       Impact factor: 5.810

5.  A Chymase Inhibitory RNA Aptamer Improves Cardiac Function and Survival after Myocardial Infarction.

Authors:  Denan Jin; Shinji Takai; Yosuke Nonaka; Satoko Yamazaki; Masatoshi Fujiwara; Yoshikazu Nakamura
Journal:  Mol Ther Nucleic Acids       Date:  2018-11-13

Review 6.  Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis.

Authors:  Shinji Takai; Denan Jin
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

7.  Increase in Chymase-Positive Mast Cells in Recurrent Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland.

Authors:  Ichita Kinoshita; Denan Jin; Masaaki Higashino; Tetsuya Terada; Yoshitaka Kurisu; Shinji Takai; Ryo Kawata
Journal:  Int J Mol Sci       Date:  2021-11-23       Impact factor: 5.923

8.  Chymase as a Novel Therapeutic Target in Acute Pancreatitis.

Authors:  Toru Kuramoto; Denan Jin; Koji Komeda; Kohei Taniguchi; Fumitoshi Hirokawa; Shinji Takai; Kazuhisa Uchiyama
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

9.  Involvement of mast cell chymase in burn wound healing in hamsters.

Authors:  Xianglin Dong; Zhongli Geng; Yang Zhao; Junjie Chen; Ying Cen
Journal:  Exp Ther Med       Date:  2012-11-27       Impact factor: 2.447

10.  Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice.

Authors:  Kentaro Terai; Denan Jin; Kenji Watase; Akihisa Imagawa; Shinji Takai
Journal:  Int J Mol Sci       Date:  2020-10-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.